Davis, David A <br/><br/>
Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-Fluorouracil therapy.  [electronic resource] 

 -  Pharmacotherapy  Mar 2005 
 - 442-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0277-0008 
<br/><br/><label>Standard No.: </label>10.1592/phco.25.3.442.61598  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Anticoagulants--adverse effects<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Colonic Neoplasms--drug therapy<br/>Drug Synergism<br/>Female<br/>Fluorouracil--adverse effects<br/>Humans<br/>International Normalized Ratio<br/>Middle Aged<br/>Warfarin--adverse effects